Investing Profile

Jonathan Tobin

InvestorVC
Partner at Brandon Capital
Photo of Jonathan Tobin, Partner at Brandon Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
10
$404.5M
CompanyStageDateRound SizeTotal Raised
NRG Therapeutics
Series BSep 2025$68M
Series ANov 2022$18M
$86M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Laurence Barker (SV Health Investors)
CatalYm
Series DJul 2024$150M
Series CNov 2022$52M
$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Oscar Slotboom (BGV (BioGeneration Ventures)), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion), Marianne Uteng (Novartis Venture Fund), Jon Edwards (Red Tree Venture Capital)
Myricx Bio
Series AJul 2024$120M
$120M
Co-investors: Stephen Thompson (Brandon Capital Partners), Maina Bhaman (Soffinova Partners)
Pheon Therapeutics
Series BMay 2024$120M
Series ASep 2022$68M
$190M
Co-investors: Rogier Rooswinkel (Forbion), Michael Gladstone (Atlas Venture)
AstronauTx
Series AOct 2023$59M
$60M
Co-investors: Simon Goldman (Albion VC), Marianne Uteng (Novartis Venture Fund), Laurence Barker (SV Health Investors)
Quench Bio
Series AJan 2020$50M
$50M
Co-investors: Bruce Booth (Atlas Venture), Josh Resnick
Atox Bio
Series FDec 2017$30M
$30M